| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |